July 21, 2016 SARC RESEARCHERS REPORT IMMUNOTHERAPY EFFECTIVE IN SELECTED SARCOMA SUBTYPES PRELIMINARY RESULTS OF SARC028 In this first investigator-led study of pembrolizumab in multiple subtypes of sarcoma, researchers reported encouraging results at the recent ASCO (American Society of Clinical Oncology) meeting. … Read more
June 3, 2016 Announcing 2016 SARC Career Development Awards Lara Davis, MD & Angela Hirbe, MD, PhD At the 2016 SARC Semiannual Meeting, June 3, 2016, SARC announced the 2016 Career Development Award recipients. Dr. Richard Gorlick, Co-chair of … Read more